Cancer Institute A national cancer institute
designated cancer center
noThumbs = true, sDelay = 8000

Stanford Lymphoma Program

Preserving quality of life through
unique and highly curative treatment technologies

Stanford Lymphoma Program

Developing revolutionary treatment
through research and innovation

Stanford Lymphoma Program

Personalizing treatment through
targeted therapies and patient customized vaccines

Stanford Lymphoma Program

National expertise in research and
treatment of Cutaneous Lymphomas

The Stanford Lymphoma Program

The Stanford Lymphoma Program is comprised of a dedicated core of individuals who have pioneered significant advances in the treatment of lymphoma. Members of this team are routinely recognized and awarded for their contributions to the treatment of lymphoma for both adults and children.

With a 40-year history of innovation, Stanford's Lymphoma Program is at the forefront of developing novel treatment approaches for lymphoma for both adults and children. Our program is a major referral center for patients across the country. Our expertise allows us to provide a comprehensive approach to patient care, including:

  • The most current and up-to-date standard of care
  • Collaborative team of lymphoma experts in medical oncology, radiation oncology, pathology and radiology that offers integrated care for patients
  • Our physicians specialize in treating all sub-types of non-Hodgkin's and Hodgkin's lymphoma
  • Extensive expertise available to handle the most complicated cases
  • State-of-the-art clinical trials bring to patients promising new treatments, such as targeted therapies, novel agents and vaccines that are often not yet available at other facilities.
  • Additionally, we offer national cooperative group clinical trials that lead the integration of new drugs and imaging techniques into front-line therapy.

Benefits to you

At Stanford Cancer Center you are cared for by a team of some of the nation’s top authorities on lymphoma.

Our pathologists have the highest level of expertise in both Non-Hodgkin's lymphoma and Hodgkin's lymphoma and use the latest technology to provide an accurate diagnosis.

Stanford physicians are pioneers who are internationally recognized leaders in the research and development of breakthrough immunotherapies and monoclonal antibodies to fight lymphoma, including rituximab (Rituxan) by Dr. Ronald Levy – now a standard component of treatment for B cell non-Hodgkin's lymphoma. For children with lymphoma, Hodgkins and Non-Hodgkins, our team has pioneed the use of low dose radiation and chemotherapy to minimize toxicity.

Types of Lymphoma


Meet Our Physicians

Find a Lymphoma physician »

Patient Resources

US News: Best Hospitals National Cancder 2011-12NCCN Guidelines for Patients

Stanford Medicine Resources:

Footer Links: